COVID ‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era
Tóm tắt
Increasing literature has linked COVID‐19 to peripheral nervous system (PNS) diseases. In addition, as we move from the pandemic to the vaccination era, literature interest is shifting towards the potential association between COVID‐19 vaccines and PNS manifestations. We reviewed published literature on COVID‐19, COVID‐19 vaccines and PNS manifestations between 1 January 2020 and 1 December 2021. For Guillain‐Barré syndrome (GBS), isolated cranial neuropathy (ICN) and myositis associated with COVID‐19, the demographic, clinical, laboratory, electrophysiological and imaging features were included in a narrative synthesis. We identified 169 studies on COVID‐19‐associated complications, including 63 papers (92 patients) on GBS, 29 papers (37 patients) on ICN and 11 papers (18 patients) on myositis. Additional clinical phenotypes included chronic inflammatory demyelinating polyneuropathy, vasculitic neuropathies, neuralgic amyotrophy, critical care‐related complications, and myasthenia gravis. PNS complications secondary to COVID‐19 vaccines have been reported during randomized clinical trials, in real‐world case reports, and during large‐scale surveillance programs. These mainly include cases of GBS, Bell's palsy, and cases of neuralgic amyotrophy. Based on our extensive review of the literature, any conclusion about a pathophysiological correlation between COVID‐19 and PNS disorders remains premature, and solely supported by their temporal association, while epidemiological and pathological data are insufficient. The occurrence of PNS complications after COVID‐19 vaccines seems limited to a possible higher risk of facial nerve palsy and GBS, to a degree that widespread access to the ongoing vaccination campaign should not be discouraged, while awaiting for more definitive data from large‐scale surveillance studies.
Từ khóa
Tài liệu tham khảo
Lou JJ, 2021, Neuropathology of COVID‐19 (neuro‐COVID): clinicopathological update, Free Neuropathol, 2, 2
Garcia‐Manzanedo S, 2020, Guillain‐Barre syndrome after Covid‐19 infection, Med Clin (Engl Ed), 155, 366
Ebrahimzadeh SA, 2021, Guillain‐Barré syndrome associated with the coronavirus disease 2019 (COVID‐19), Neurology Clin Pract
Amira Sidig K. A HussienAbbasher MohammedAbbasher AbbasherHussien.COVID‐19 and Guillain‐Barre syndrome case report. doi:10.21203/rs.3.rs-48327/v1(2020).
Hutchins KL, 2020, COVID‐19‐associated bifacial weakness with paresthesia subtype of Guillain‐Barre syndrome, AJNR Am J Neuroradiol, 41, 1707
Singh R, 2021, Association of Guillain‐Barre syndrome with COVID‐19: a case report and literature review, Cureus, 13, e13828
Enrique Estévez‐Rivera JB‐H, 2020, Mononeuritis multiplex associated with Sars‐Cov2‐Covid‐19 Infection: case report, Int J Neurol Neurother, 7
Soliman SB, 2020, Peripheral polyneuropathy associated with COVID‐19 in two patients: A musculoskeletal ultrasound case report, J Med Ultrasound, 28, 249, 10.4103/JMU.JMU_150_20
Haroun MW, 2021, Rhabdomyolysis in COVID‐19 patients: a retrospective observational study, Cureus, 13, e12552
Zhang Q, 2020, A rare presentation of coronavirus disease 2019 (COVID‐19) induced viral myositis with subsequent rhabdomyolysis, Cureus, 12, e8074
Gokhale Y, 2020, Dermatomyositis during COVID‐19 Pandemic (a case series): is there a cause effect relationship?, J Assoc Physicians India, 68, 20
Kitamura M, 2021, Clinically amyopathic dermatomyositis during the COVID‐19 pandemic, Oxf Med Case Reports, 061, 2021
Sriwastava S, 2020, New onset of ocular myasthenia gravis in a patient with COVID‐19: a novel case report and literature review, J Neurol
Carod‐Artal FJ, 2021, Post‐COVID‐19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved, Rev Neurol, 72, 384
Abrams RMC, 2021, Small fiber neuropathy associated with SARS‐CoV‐2 infection, Muscle Nerve
Waheed S, 2021, Neurological complications of COVID‐19: Guillain‐Barre syndrome following Pfizer COVID‐19 vaccine, Cureus, 13, e13426
Bonifacio GB, 2021, Bilateral facial weakness with paraesthesia variant of Guillain‐Barre syndrome following Vaxzevria COVID‐19 vaccine, J Neurol Neurosurg Psychiatry
Shemer A, 2021, Peripheral facial nerve palsy following BNT162b2 (COVID‐19) vaccination, Isr Med Assoc J, 23, 143
Manea MM, 2021, Multiple cranial nerve palsies following COVID‐19 vaccination‐case report, Acta Neurol Scand
Abdelrhman Abo‐Zed AP, 2021, Guillain‐Barré syndrome, or acute on chronic inflammatory demyelinating polyneuropathy, following Moderna Covid‐19 vaccine, Chest, 160, S1
Hughes RA, 1996, Immunization and risk of relapse of Guillain‐Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy, Muscle Nerve, 19, 1230
Victoria Chisholm NB, 2021, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and vaccinations: examining the current literature on vaccinations and the onset or worsening of CIDP symptoms, touchNeurology, 17, 3
Mack M, 2021, Rhabdomyolysis secondary to COVID‐19 vaccination, Cureus, 13, e15004